We are updating our Privacy Policy and Terms and Conditions to help you clearly understand how your personal information is collected, stored and managed. Learn More
Menu Back toOversight of Clinical Monitoring: Trends and Strategies

Oversight of Clinical Monitoring: Trends and Strategies


DIA is pleased to present a three-part online training series focusing on clinical monitor oversight.  Hear from experienced faculty on the trends impacting monitors, requirements, approaches, selection, and how to manage a site monitor’s performance. This course also focuses on the elements of risk-based monitoring.
Course Level: Intermediate

What you will learn

  • Trends in the clinical development landscape driving change
  • ICH and FDA requirements for site monitoring
  • Current approaches to risk-based monitoring
  • Warning signs and problems with site monitors
  • Managing site monitors and their performance
  • Common errors made in site monitoring
  • Metrics used to measure site monitor performance

Who should attend?

  • Professionals who work with or manage site monitors
  • Sponsors from small-to-mid-size pharmaceutical, biotechnology, and device companies who have clinical operations responsibilities including interaction with sourcing site monitors

Learning objectives

At the conclusion of this activity, participants should be able to:

  • Describe the current factors impacting clinical development necessitating change
  • Recognize the impact on approaches to risk-based monitoring from FDA Guidance and TransCelerate viewpoints
  • Identify audit trends and inspection findings relative to site monitoring
  • Discuss how to develop measurable expectations and objectives for site monitors
  • Identify best practices in managing site monitors